The Globalization of Innovation: Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market
Center for Entrepreneurship and Research Commercialization, Pratt School of Engineering; Stanford University - Arthur & Toni Rembe Rock Center for Corporate Governance
Ben A. Rissing
Massachusetts Institute of Technology (MIT) - Behavioral Policy Science (BPS)
Duke University - Department of Sociology - Director, Center on Globalization, Governance & Competitiveness
Harvard University - Labor and Worklife Program
Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These relationships largely appear to be symbiotic. As a result of the movement of research to their countries, Indian and Chinese scientists are rapidly developing the ability to innovate and create their own intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments of the pharmaceutical global value chain.
Number of Pages in PDF File: 67
Keywords: pharmaceuticals, innovaiton, R&D, value chain, China, Indiaworking papers series
Date posted: June 11, 2008 ; Last revised: February 23, 2014
© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.
This page was processed by apollo3 in 0.453 seconds